Lateral Flow Assays Market Projected to Reach $12.1 Billion by 2030
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Read More
Search Results for: infectious diseases
Quanterix Accelerator Laboratory Gains New York State Clinical Lab Permit
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
Read More
New Guidance on Modifications to Antimicrobial Susceptibility Testing
The new document provides framework for drug developers on appropriate use and modification of reference AST methods during antimicrobial development.
Read More
Korean Researchers Develop SERS Platform 100,000 Times More Sensitive Than ELISA for Alzheimer’s Detection
The surface-enhanced Raman spectroscopy platform can detect amyloid beta biomarkers at ultra-low concentrations in body fluids, potentially enabling earlier diagnosis and monitoring of disease progression.
Read More
Pride & Prevention: New Hope in the Fight Against HIV
Clinical labs help drive early HIV detection and support efforts to prevent its spread.
Read More